All You Need to Know About Semaglutide for Weight Loss
Semaglutide is a once-weekly GLP-1 receptor agonist — the active ingredient in Wegovy and Ozempic — that supports weight loss by mimicking a natural appetite hormone: it reduces hunger, increases fullness and slows digestion, helping you eat less without constant cravings. In the STEP 1 trial it produced about 14.9% mean weight loss over 68 weeks, and a Phase III trial in Indian adults confirmed around 11.25% at 24 weeks. This guide covers how it works, Wegovy vs Ozempic, dosing, side effects, foods to avoid, and who may be eligible. [22]
Semaglutide for Weight Loss in India: Why It Matters
Weight management is shaped by far more than diet and exercise — hormones, metabolism, appetite regulation, genetics and lifestyle all play a role. Semaglutide, a GLP-1 receptor agonist and the active ingredient in Wegovy and Ozempic, addresses the hormonal side directly by regulating appetite and increasing satiety. Originally developed for type 2 diabetes, it's now widely used for chronic weight management.
According to the ICMR-INDIAB study, India is home to 254 million adults with generalised obesity and 351 million with abdominal obesity, plus an estimated 89.8 million adults living with type 2 diabetes — making medically supervised weight management more important than ever. [21]
For many people in India, persistent cravings and difficulty maintaining weight loss make traditional approaches challenging. With semaglutide's growing popularity — and generic semaglutide entering the market following patent expiry in 2026 — many want to understand how it works, its side effects, expected results, and whether Wegovy or Ozempic suit long-term use. At Karespot, semaglutide-based plans are guided by qualified Internal Medicine specialists and Endocrinologists who provide personalised supervision, monitoring and lifestyle support. [2, 3]
What Is Semaglutide?
Semaglutide is a prescription GLP-1 receptor agonist, originally developed to manage blood sugar in type 2 diabetes and now widely used for chronic weight management. It is the active ingredient in Wegovy and Ozempic, both given as once-weekly injections under medical supervision. It mimics GLP-1, a natural hormone involved in appetite regulation, digestion, insulin release and fullness.
By activating GLP-1 receptors, semaglutide helps reduce hunger cravings, slow gastric emptying and increase satiety — which may help individuals consume fewer calories and better manage weight over time. [3, 5]
How Semaglutide Works for Weight Loss
Unlike approaches that focus only on cutting calories, semaglutide works at a hormonal level. As a GLP-1 receptor agonist, it mimics glucagon-like peptide-1 — a hormone released after eating — and activates GLP-1 receptors in the brain and digestive system to reduce cravings, increase fullness and slow gastric emptying, so you stay satisfied longer after meals.
Long-term weight loss is difficult partly because the body responds to calorie restriction by increasing hunger signals and reducing metabolic efficiency. Semaglutide helps counter some of these responses, making it easier for some people to reduce portions and avoid frequent snacking without constant hunger. [6] Clinical studies including the STEP trials and the SELECT cardiovascular outcomes trial confirm meaningful, sustained weight reduction when combined with balanced nutrition, activity and lifestyle support; SELECT also showed a 20% reduction in major adverse cardiovascular events. [10, 20]
How semaglutide targets appetite and metabolism
Semaglutide acts on appetite-regulating centres in the hypothalamus, helping reduce hunger and improve portion control. Many users report fewer cravings, reduced emotional eating and better control over daily intake — the STEP 5 trial confirmed meaningful reductions in emotional and uncontrolled eating. [8] It also supports metabolic health by improving insulin response and stabilising blood sugar — particularly relevant for Indian patients, who face higher insulin-resistance risk due to the "thin-fat" phenotype common in South Asians, where metabolic risk can appear at lower BMI values. [21]
- Improved insulin response and better blood-sugar control
- Reduced glucose fluctuations and support for long-term metabolic health
- Particularly beneficial for visceral fat, the metabolically harmful fat prevalent in Indian patients
At Karespot, semaglutide-based plans focus on medical safety, metabolic health and sustainable long-term results rather than rapid short-term loss. Treatment is supervised by experienced Internal Medicine specialists and Endocrinologists, combining evidence-based guidance with personalised nutrition, lifestyle support and progress monitoring.
Who Can Take Semaglutide for Weight Loss?
Semaglutide may be prescribed for adults with obesity or excess weight, especially when diet and exercise alone haven't produced sustainable results. In general it may be recommended for a BMI of 30 kg/m² or higher, or 27 kg/m² or higher with weight-related conditions such as type 2 diabetes, high blood pressure, insulin resistance, sleep apnoea or high cholesterol. In India, lower BMI thresholds may apply given higher metabolic risk in South Asians at lower BMI.
It may also benefit people struggling with persistent hunger, emotional eating or portion control. Because semaglutide affects appetite, metabolism and blood sugar, suitability should always be assessed by qualified professionals. [23]
Semaglutide carries an FDA boxed warning regarding thyroid C-cell tumours observed in rodent studies and is contraindicated in anyone with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2). Pregnant or breastfeeding individuals are generally advised to avoid it unless medically recommended. [23]
At Karespot, semaglutide programmes are personalised to each individual's BMI, metabolic health, medical history and long-term goals. Our specialists provide online consultations and ongoing supervision to help ensure Wegovy and Ozempic are used safely and effectively.
How Much Weight Can You Lose on Semaglutide?
Results vary with body weight, metabolic health, dose progression, nutrition, activity and adherence. The STEP trial programme provides the strongest evidence: in STEP 1, once-weekly semaglutide 2.4 mg alongside diet and exercise produced a mean 14.9% loss of initial body weight over 68 weeks versus 2.4% with placebo. The two-year STEP 5 trial confirmed sustained loss of about 15.2% at 104 weeks, and a Phase III trial in Indian adults reported non-inferior loss of 11.25% at 24 weeks.
Semaglutide is not designed for rapid or unrealistic weight loss. The STEP 1 extension showed participants who stopped regained about two-thirds of their prior weight loss within a year, reinforcing the importance of long-term treatment planning. [18]
Semaglutide Injection Dosages
Semaglutide is started low and increased gradually over several weeks — a process called titration — to help the body adjust and reduce GI side effects such as nausea and bloating. It's given as a once-weekly injection under the skin of the abdomen, thigh or upper arm. Higher doses don't always mean faster weight loss; the best dose balances benefit, tolerability and long-term sustainability under medical supervision.
1–4
5–8
9–12
13–16
Maint.
| Wegovy dosing schedule | |
|---|---|
| Weeks 1–4 | 0.25 mg |
| Weeks 5–8 | 0.5 mg |
| Weeks 9–12 | 1 mg |
| Weeks 13–16 | 1.7 mg |
| Maintenance dose | 2.4 mg |
| Ozempic dosing schedule | |
|---|---|
| Initial dose | 0.25 mg |
| Standard dose | 0.5 mg |
| Higher dose (if needed) | 1 mg |
| Maximum approved dose | 2 mg |
At Karespot, dosage plans are personalised and closely monitored. Progression is adjusted to each individual's metabolic health, treatment response and side-effect tolerance, while ongoing monitoring, nutritional guidance and regular follow-up help ensure safe, sustainable outcomes.
How Do I Stop Taking Semaglutide?
Semaglutide should not be stopped abruptly without medical guidance. Because it affects appetite, digestion and metabolism, stopping can lead to increased hunger, changed eating patterns and weight regain over time. The STEP 1 extension found mean body weight returned toward baseline within a year of stopping — about two-thirds of prior weight loss regained.
Some people stop after reaching their goals; others discontinue due to side effects, pregnancy planning, cost or health changes. Providers may recommend gradual dose adjustments or alternative strategies depending on response and long-term goals. [18]
At Karespot, decisions about stopping are guided by specialists who assess metabolic health, weight stability and long-term goals. We provide structured transition plans with nutrition support, lifestyle guidance and ongoing monitoring to help reduce the risk of weight regain after treatment.
What Are the Side Effects of Semaglutide?
Because semaglutide influences appetite, digestion and blood sugar, most common side effects are gastrointestinal — nausea, vomiting, diarrhoea, constipation, bloating, stomach discomfort and reduced appetite. These are usually mild to moderate and tend to improve as the body adjusts. Nausea is especially common early or after dose increases, since semaglutide slows gastric emptying.
Eating smaller meals, staying hydrated, avoiding heavy fatty foods and following the prescribed dose-escalation schedule can help reduce symptoms. [13]
Common side effects
- Nausea and vomiting
- Diarrhoea and constipation
- Bloating and stomach discomfort
- Reduced appetite
- Acid reflux or burping
- Fatigue and mild headaches
Less common but serious side effects
Get prompt care for severe or persistent abdominal pain, signs of pancreatitis, gallbladder problems, persistent vomiting or dehydration, allergic reactions, changes in kidney function or severe dizziness. Semaglutide is contraindicated with a personal or family history of medullary thyroid carcinoma (MTC) or MEN2. [13, 23]
At Karespot, treatment is closely supervised by GLP-1 specialist doctors who monitor response, dose tolerance, GI symptoms and metabolic health. Personalised dose escalation, nutritional guidance, hydration support and regular follow-up help minimise side effects while supporting safer, more sustainable outcomes.
Ozempic vs Wegovy: What Is the Difference?
Ozempic and Wegovy both contain semaglutide, but they're approved for different primary uses and prescribed at different strengths. Ozempic is mainly approved for type 2 diabetes (with weight loss as a secondary benefit); Wegovy is specifically approved for chronic weight management. Wegovy uses a higher maintenance dose (2.4 mg vs up to 2 mg), which may contribute to greater average weight loss.
| Feature | Ozempic | Wegovy |
|---|---|---|
| Active ingredient | Semaglutide | Semaglutide |
| Primary approval | Type 2 diabetes management | Chronic weight management |
| Weekly maintenance dose | Up to 2 mg | Up to 2.4 mg |
| Main treatment goal | Blood sugar control | Weight loss and obesity management |
| Administration | Once-weekly injection | Once-weekly injection |
Sources: Ozempic vs Wegovy comparisons and prescribing information. [15, 23]
Which is better for weight loss?
Wegovy is generally considered the semaglutide formulation designed for chronic weight management because it uses a higher maintenance dose. However, the best option depends on metabolic health, diabetes status, medical history, goals and individual response. [15]
At Karespot, Ozempic and Wegovy plans are personalised by GLP-1 specialist doctors based on each patient's metabolic profile, BMI, diabetes status and long-term goals — with online consultations, nutritional guidance and lifestyle support for safe, sustainable outcomes.
Foods to Avoid While on Semaglutide
There's no strict semaglutide diet, but because Wegovy and Ozempic slow gastric emptying, some people become more sensitive to heavy, greasy and highly processed foods. High-fat, fried, heavily processed or very sugary foods may aggravate nausea, bloating, acid reflux or stomach discomfort — especially early on or after dose increases.
For Indian patients, this may mean limiting very oily curries, deep-fried snacks (samosas, pakoras, puri), high-sugar sweets (mithai, sugary lassi) and large portions of high-glycaemic foods like white rice. Alcohol also warrants caution: excess can worsen dehydration, GI irritation, blood-sugar swings and nausea, and heavy intake may raise pancreatitis risk. [16, 13]
Better food choices during treatment
- Lean protein: dal, paneer, tofu, eggs, chicken, fish
- Fibre-rich vegetables and fruit: sabzi, leafy greens, amla
- Whole grains: brown rice, millets (bajra, jowar, ragi), whole-wheat roti
- Adequate hydration: water, coconut water, low-fat buttermilk (chaas)
- Smaller, balanced meals eaten slowly
- Mindful eating: stop when comfortably full
At Karespot, nutritional guidance is personalised to regional Indian food culture — from North Indian wheat-based diets to South Indian rice-based meals — emphasising individualised meal planning, protein-focused nutrition, hydration strategies and sustainable habits to minimise side effects while supporting long-term results.
Is Semaglutide Worth the Risk?
For many people with obesity or metabolic conditions, semaglutide can offer significant benefits under proper supervision. Beyond weight loss, the SELECT trial showed a 20% reduction in major adverse cardiovascular events in people with overweight or obesity even without diabetes, and the FLOW trial showed a 24% reduction in kidney-disease progression in type 2 diabetes with chronic kidney disease. Providers weigh these against the health risks of untreated obesity.
Untreated obesity carries risks including type 2 diabetes, cardiovascular disease, hypertension, sleep apnoea and fatty liver disease — all highly prevalent in India. For many eligible individuals, the benefits of sustained weight loss may outweigh the manageable risks when properly monitored. [20, 21]
| Potential benefits | Potential risks & side effects |
|---|---|
| Significant, clinically meaningful weight loss | Nausea and digestive discomfort (most common, often temporary) |
| Better appetite control, satiety and fewer cravings | Vomiting, diarrhoea, constipation or bloating |
| Improved blood sugar and insulin sensitivity | Gallbladder complications |
| 20% reduction in major cardiovascular events (SELECT) | Pancreatitis (rare) |
| 24% reduction in kidney-disease progression (FLOW) | Dehydration |
| Support for overall cardiometabolic health | Contraindicated with personal/family history of MTC or MEN2 (boxed warning) |
At Karespot, treatment is guided by specialists who assess each patient's metabolic profile, obesity-related risks and long-term goals. Through personalised supervision, nutritional counselling and ongoing monitoring, we focus on balancing effectiveness with safety for sustainable outcomes.
Frequently Asked Questions About Semaglutide
Is semaglutide the same as Ozempic and Wegovy?
What foods should I avoid while taking semaglutide?
How much weight can you lose on semaglutide?
Is semaglutide safe for long-term use?
Do I still need lifestyle changes while taking semaglutide?
Is semaglutide available in India?
Can semaglutide be used without diabetes?
What happens if I stop taking semaglutide?
The Holistic Kare Programme: More Than Just a Prescription
Starting semaglutide is only the beginning. Research consistently shows GLP-1 therapy produces the best long-term outcomes when medication is embedded within a structured, multidisciplinary programme — not prescribed in isolation. [1] The Kare Programme is built around three pillars working as one integrated team.
Why the integrated approach matters
Each pillar reinforces the others. When nausea is severe, the nutritionist adjusts meal composition while the physician reviews whether a dose pause is appropriate. When emotional eating re-emerges, the psychologist and nutritionist coordinate strategies. When weight loss plateaus, the physician reviews metabolic markers, the nutritionist recalibrates energy targets and the psychologist addresses motivational barriers. This is the standard of care specialist obesity clinics in the UK and US have offered in person for years — Karespot brings it to Indian patients entirely online.
Ready to explore doctor-supervised semaglutide treatment?
Karespot's MBBS + MD (Internal Medicine) doctors and Endocrinologists provide personalised, medically supervised GLP-1 care across India, with a dietitian and clinical psychologist alongside. Eligibility, dosing, side effects and progress reviews are managed at every step.
Check Your Eligibility → Explore more guides on Kare Hub →Hall KD, Kahan S. Maintenance of Lost Weight and Long-Term Management of Obesity. Med Clin North Am. 2018.
doi.org/10.1016/j.mcna.2017.08.012Fornes A, et al. Once-Weekly Semaglutide for Weight Management: A Clinical Review. J Pharm Technol. 2022.
doi.org/10.1177/87551225221092681Kommu S, et al. Semaglutide. StatPearls. 2024.
ncbi.nlm.nih.gov/books/NBK603723Wilding JPH, et al. Long-Term Weight Loss Effects of Semaglutide in Obesity without Diabetes (SELECT). Nat Med. 2023.
pmc.ncbi.nlm.nih.gov — PMC10533252How Does Semaglutide Work? Mayo Clinic Diet. 2024.
diet.mayoclinic.org — How Does Semaglutide WorkJastreboff AM, et al. Tirzepatide as Compared with Semaglutide for the Treatment of Obesity. NEJM. 2023.
pmc.ncbi.nlm.nih.gov — PMC11674233Wharton S, et al. Once-weekly semaglutide 7.2 mg in adults with obesity (STEP UP). Lancet Diabetes Endocrinol. 2025.
thelancet.com — STEP UPWharton S, et al. Estimating Changes in Eating Behaviors Following Semaglutide 2.4 mg (STEP 5). Diabetes Obes Metab. 2024.
pmc.ncbi.nlm.nih.gov — PMC9007016Garvey WT, et al. Two-year effects of semaglutide in adults with overweight or obesity (STEP 5). Nat Med. 2022.
ncbi.nlm.nih.gov — PMC9556320Ryan DH, et al. Semaglutide Effects on Cardiovascular Outcomes in People with Overweight or Obesity. Nat Med. 2023.
pmc.ncbi.nlm.nih.gov — PMC9272494Semaglutide Dosage Guide. Drugs.com. 2026.
drugs.com — Semaglutide DosageFrias JP, et al. Cagrilintide 2.4 mg with semaglutide 2.4 mg in type 2 diabetes (phase 2). Lancet. 2023.
thelancet.com — CagriSema phase 2Fahim SA, et al. Comparative Safety and Side Effects of Semaglutide and Tirzepatide. Biomed Pharmacother. 2025.
doi.org/10.1016/j.biopha.2025.118731Ozempic vs Wegovy: Key Differences, Benefits & Risks. Metropolis Healthcare. 2026.
metropolisindia.com — Ozempic vs WegovyWhat's the Difference Between Ozempic and Wegovy? Medical News Today.
medicalnewstoday.com — Ozempic vs WegovyFood List When Taking Semaglutide and What to Avoid. Healthline. 2026.
healthline.com — Semaglutide Food ListPillarisetti L, et al. Semaglutide: Double-Edged Sword with Risks and Benefits. Cureus. 2025.
pmc.ncbi.nlm.nih.gov — PMC11790292Wilding JPH, et al. Weight Regain After Withdrawal of Semaglutide: STEP 1 Trial Extension. Diabetes Obes Metab. 2022.
pmc.ncbi.nlm.nih.gov — PMC9542252Wilding JPH, et al. Long-Term Weight Loss Effects of Semaglutide in Obesity without Diabetes (SELECT). Nat Med. 2023.
pmc.ncbi.nlm.nih.gov — PMC11271387Lincoff AM, et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes (SELECT). NEJM. 2023.
doi.org/10.1056/NEJMoa2307563Phase III Randomized Trial of Semaglutide in Indian Adults with Obesity. PMC. 2026.
pmc.ncbi.nlm.nih.gov — PMC13054606Alabduljabbar K, et al. Impact of Once-Weekly Semaglutide 2.4 mg: A Focus on the STEP Trials. Nutrients. 2022.
ncbi.nlm.nih.gov — PMC9182751FDA Prescribing Information for Ozempic (Semaglutide). FDA. 2025.
accessdata.fda.gov — Ozempic LabelDr. Prakrati Garg is a PhD-qualified Biotechnology researcher and Content Strategist at Karespot. With deep expertise in herbal drug development, nanotechnology and advanced drug-delivery systems, she brings a rigorous scientific lens to health and wellness content. Her research background — including published work and patents in herbal-based formulations — informs her ability to translate complex medical and nutritional science into clear, evidence-based insights.
Dr. Sana Umar is an Assistant Professor at Doon Medical College and Medical Reviewer at Karespot. A Clinical Pathologist with FRCP credentials and NMC registration (Reg. 8506), she ensures all clinical content aligns with current prescribing guidelines and evidence-based best practices in weight management and metabolic medicine.
Weight loss can feel like a lonely road. At Karespot, we believe you should never have to walk it alone.
Karespot is an end-to-end digital health platform connecting individuals across India with qualified MD Internal Medicine doctors and Endocrinologists for medically supervised GLP-1 weight management. Conceived in the UK by leading doctors, biologists and pharmacologists, the Karespot programme is tailored for the Indian population and available via telehealth from anywhere in India. All treatment plans are developed only after a thorough medical review by a qualified specialist.
Every Karespot patient is supported by a holistic team: a doctor who understands your metabolic health, a registered dietician who adapts your nutrition to your real life, a clinical psychologist who helps you understand your relationship with food, and a lifestyle health coach who helps you build habits that last.
Delhi & NCR: New Delhi, Noida, Gurugram, Faridabad, Ghaziabad
Uttarakhand: Dehradun, Haridwar, Roorkee, Haldwani, Rudrapur, Rishikesh, Kashipur, Pithoragarh, Nainital, Kotdwar
Uttar Pradesh: Lucknow, Kanpur, Agra, Varanasi, Prayagraj, Noida, Ghaziabad, Meerut, Gorakhpur, Aligarh, Moradabad, Bareilly
Maharashtra: Mumbai, Pune, Nagpur, Nashik, Aurangabad (Chhatrapati Sambhajinagar), Solapur, Kolhapur, Thane, Navi Mumbai
Karnataka: Bengaluru, Mysuru, Mangaluru, Hubballi-Dharwad, Belagavi
Telangana: Hyderabad, Warangal, Nizamabad, Karimnagar
Punjab & Chandigarh: Amritsar, Ludhiana, Jalandhar, Patiala, Chandigarh, Mohali
Other Cities: Chennai, Kolkata, Ahmedabad, Jaipur, Surat, Kochi, Indore, Coimbatore, Bhopal, Visakhapatnam, Thiruvananthapuram
Medical Disclaimer: This article is for general informational purposes only and does not constitute medical advice. Semaglutide (Wegovy, Ozempic) is a prescription medicine that must be prescribed and supervised by a qualified Internal Medicine specialist or Endocrinologist. Always consult your Karespot doctor before starting, stopping or adjusting any treatment.
